Attached files
file | filename |
---|---|
EX-99.1 - SERACARE LIFE SCIENCES INC | v210839_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of Earliest Event
Reported): February 11, 2011
SeraCare Life
Sciences, Inc.
(Exact name
of registrant as specified in its charter)
Delaware
|
1-34105
|
33-0056054
|
||
(State or other
jurisdiction
|
(Commission
|
(I.R.S.
Employer
|
||
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
37 Birch Street, Milford,
Massachusetts
|
01757
|
|
(Address of principal
executive offices)
|
(Zip
Code)
|
Registrant's telephone number, including
area code: (508)
244-6400
Not
Applicable
Former name
or former address, if changed since last report
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02 Results of
Operations and Financial Condition.
On February 11, 2011, we issued a press
release announcing our financial results for the quarter ended December 31,
2010. A copy of the press release is attached hereto as exhibit 99.1
and incorporated by reference herein.
The information in this Item 2.02 and
the press release attached hereto shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or the
Exchange Act, or otherwise subject to the liabilities of that section, nor shall
they be deemed incorporated by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act, regardless of any general
incorporation language in such filing.
Item
9.01 Financial Statements
and Exhibits.
(d) Exhibits
Exhibit No.
|
Description
|
|
99.1
|
Press Release issued by SeraCare
Life Sciences, Inc. dated February 11,
2011
|
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
SeraCare Life Sciences,
Inc.
|
||
February 11,
2011
|
By:
|
/s/ Gregory A.
Gould
|
Name: Gregory A.
Gould
|
||
Title: Chief Financial Officer,
Treasurer and
Secretary
|
Exhibit Index
Exhibit No.
|
Description
|
|
99.1
|
Press Release issued by SeraCare
Life Sciences, Inc., dated February 11,
2011.
|